Daniil Gataulin
Stock Analyst at Chardan Capital
(3.04)
# 2,671
Out of 5,051 analysts
72
Total ratings
34.8%
Success rate
4.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OCUL Ocular Therapeutix | Reiterated: Buy | $21 → $23 | $7.56 | +204.23% | 3 | Jun 25, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $11 → $13 | $4.64 | +180.17% | 3 | Jun 17, 2026 | |
| CRVO CervoMed | Reiterated: Buy | $21 | $2.51 | +736.65% | 7 | May 17, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $36 → $35 | $10.38 | +237.19% | 2 | May 14, 2026 | |
| OCS Oculis Holding AG | Reiterated: Buy | $51 → $53 | $7.88 | +572.59% | 3 | May 12, 2026 | |
| KOD Kodiak Sciences | Upgraded: Buy | $14 → $61 | $99.26 | -38.55% | 6 | May 11, 2026 | |
| CGTX Cognition Therapeutics | Reiterated: Buy | $8 → $4 | $0.8569 | +366.80% | 3 | May 8, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $5 → $7 | $0.9472 | +639.02% | 8 | May 7, 2026 | |
| ZURA Zura Bio | Reiterated: Buy | $10 → $11 | $4.00 | +175.00% | 4 | May 7, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $29 | $3.32 | +773.49% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $21.84 | +69.41% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $7.77 | +569.24% | 8 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $1 | $0.5851 | +70.91% | 6 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.96 | +304.04% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $2.26 | +740.71% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0744 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $9.37 | n/a | 2 | Feb 15, 2023 |
Ocular Therapeutix
Jun 25, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $7.56
Upside: +204.23%
Opus Genetics
Jun 17, 2026
Reiterated: Buy
Price Target: $11 → $13
Current: $4.64
Upside: +180.17%
CervoMed
May 17, 2026
Reiterated: Buy
Price Target: $21
Current: $2.51
Upside: +736.65%
MeiraGTx Holdings
May 14, 2026
Reiterated: Buy
Price Target: $36 → $35
Current: $10.38
Upside: +237.19%
Oculis Holding AG
May 12, 2026
Reiterated: Buy
Price Target: $51 → $53
Current: $7.88
Upside: +572.59%
Kodiak Sciences
May 11, 2026
Upgraded: Buy
Price Target: $14 → $61
Current: $99.26
Upside: -38.55%
Cognition Therapeutics
May 8, 2026
Reiterated: Buy
Price Target: $8 → $4
Current: $0.8569
Upside: +366.80%
Ocugen
May 7, 2026
Reiterated: Buy
Price Target: $5 → $7
Current: $0.9472
Upside: +639.02%
Zura Bio
May 7, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $4.00
Upside: +175.00%
EyePoint
May 6, 2026
Reiterated: Buy
Price Target: $29
Current: $3.32
Upside: +773.49%
May 5, 2026
Reiterated: Buy
Price Target: $37
Current: $21.84
Upside: +69.41%
Jan 28, 2026
Reiterated: Buy
Price Target: $52
Current: $7.77
Upside: +569.24%
Jan 2, 2026
Reiterated: Hold
Price Target: $3 → $1
Current: $0.5851
Upside: +70.91%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $16
Current: $3.96
Upside: +304.04%
Dec 23, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $2.26
Upside: +740.71%
Jun 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0744
Upside: n/a
Feb 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $9.37
Upside: n/a